Blog - INTERNET MÉDICA

Fibrilação Atrial: Artigos de Revisão Online (Atrial Fibrillation: Reviews)

Por Paulo Leite 15/07/2019

■ Rigidez do Átrio Esquerdo: Preditor de Recorrência de Fibrilação Atrial após Ablação por Cateter de Radiofrequência – Revisão Sistemática e Metanálise

Correia, Eduardo Thadeu de Oliveira et al

Arq. Bras. Cardiol., May 2019, vol.112, no.5, p.501-508

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000500501&lng=en&nrm=iso&tlng=pt (portuguese)

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2019000500501&lng=en&nrm=iso&tlng=en (english)

■ The impact of cateter ablation for atrial fibrillation in heart failure

Konstantinos Moschonas, Adam Nabeebaccus, Darlington O. Okonko et al

J Arrhythm. 2019 Feb; 35(1): 33–42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373662/

■ Sex differences in quality of life in patients with atrial fibrillation: a systematic review

Linn Arvidsson Strømnes, Helene Ree, Knut Gjesdal, Inger Ariansen

J Am Heart Assoc. 2019 Apr 16; 8(8): e010992

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507196/

■ Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials

K Wang, R D Lopes, M R Patel et al

European Heart Journal 2019, vol 40 (19): 1492-1500

https://academic.oup.com/eurheartj/issue/40/19

■ A decade of catheter ablation of cardiacarrhythmias in Sweden: ablation practices and outcomes

F Holmqvist, Milos Kesek, A Englund et al

European Heart Journal 2019, vol 40 (10): 820-830

https://academic.oup.com/eurheartj/article/40/10/820/5173692

■ Atrial fibrillation ablation in practice: assessing CABANA generalizability

P A Nosewworth, B J Gersh, D M Kent et al

European Heart Journal 2019, vol 40 (16): 1257-1264

https://academic.oup.com/eurheartj/article/40/16/1257/5381200

■ Ablation of atrial fibrillation in patients with Brugada syndrome: a systematic review of the literature

Moisés Rodríguez‐Mañero, Bahij Kreidieh, Miguel Valderrábano et al

J Arrhythm. 2019 Feb; 35(1): 18–24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373661/

■ Efficacy of ablation lesion sets in addition to pulmonary vein isolation for paroxysmal atrial fibrillation: findings from the SMASH-AF meta-analysis study cohort

Andrew Cluckey, Alexander C. Perino, Fahd N. Yunus et al

J Am Heart Assoc. 2019 Jan 8; 8(1): e009976

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405732/

■ The impact of catheter ablation for atrial fibrillation in heart failure

Konstantinos Moschonas, Adam Nabeebaccus, Darlington O. Okonko et al

J Arrhythm. 2019 Feb; 35(1): 33–42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373662/

■ Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature

Michelle T. Long, Darae Ko, Lindsay M. Arnold et al

Therap Adv Gastroenterol. 2019; vol 12: 1756284819832237

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448121/

■ Association of atrial fibrillation and gastroesophageal reflux disease: natural and therapeutic linkage ot the two common diseases

Toru Maruyama, Mitsuhiro Fukata, Koichi Akashi

J Arrhythm. 2019 Feb; 35(1): 43–51

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373829/

■ Atrial fibrillation in the elderly

Pablo Díez-Villanueva, Fernando Alfonso

J Geriatr Cardiol. 2019 Jan; 16(1): 49–53

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379238/

■ Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis

Alireza Sepehri Shamloo, Nikolaos Dagres, Boris Dinov et al

Int J Cardiol Heart Vasc. 2019 Mar; 22: 132–138

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356021/

■ Postoperative atrial aibrillation: Evaluation of its economic impact on the costs of cardiac surgery

Hernández-Leiva, Edgar, Alvarado, Paula and Dennis, Rodolfo José

Braz. J. Cardiovasc. Surg., Apr 2019, vol.34, no.2, p.179-186

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382019000200179&lng=en&nrm=iso

■ Stroke risk stratification in atrial fibrillation: a review of common risk factors

Oreoluwa Oladiran, Ifeanyi Nwosu

J Community Hosp Intern Med Perspect. 2019, vol 9(2): 113–120

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484493/

■ Ibrutinib increase the risk of hypertension and atrial fibrillation: systematic review and meta-analysis

Daniel Caldeira, Daniela Alves, João Costa, Joaquim J. Ferreira, Fausto J. Pinto

PLoS One. 2019; vol 14(2): e0211228

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382095/

■ The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights

Loryn J. Bohne, Dustin Johnson, Robert A. Rose et al

Front Physiol. 2019; vol 10: 135.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399657/

■ II Diretrizes Brasileiras de Fibrilação Atrial.

Magalhães, LP et al.

Arq. Bras. Cardiol., Abr 2016, vol.106, no.4, suppl.2, p.1-22.

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016003100001&lng=en&nrm=iso

■ 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

P Kirchhof, S Benussi, D Kotecha et al

Europena Heart Journal 2016, vol 37 (38): 2893-2962

https://academic.oup.com/eurheartj/article/37/38/2893/2334964

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Novo endereço:

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

– Centro Médico Unimed BH/Contagem/Pedro I

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com

Insuficiência Cardíaca: Artigos de Revisão Online (Heart Failure: Reviews)

Por Paulo Leite 13/07/2019

■ Heart failure guidelines: What you need to know about the 2017 focused update

L H Haselhuhn, D J Brotman, I S Wittstein

Cleveland Clinic Journal of Medicine 2019, vol 86 (2): 123-139

https://www.mdedge.com/ccjm/article/193385/cardiology/heart-failure-guidelines-what-you-need-know-about-2017-focused-update

■ Exercise training and heart failure: a review of the literature

Card Fail Rev. 2019 Feb; 5(1): 57–61.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396064/

■ Current landscape of heart failure gene therapy

Jake M. Kieserman, Valerie D. Myers, Praveen Dubey, Joseph Y. Cheung, Arthur M. Feldman

J Am Heart Assoc. 2019 May 21; 8(10): e012239

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585330/

■ A comprehensive review of chronic heart failure pharmacotherapy treatment approaches in African Americans

Frank Tillman, Jennifer Kim, Tanya Makhlouf, Leah Osae

Ther Adv Cardiovasc Dis. 2019; 13: 1753944719840192

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535737/

■ Heart failure with preserved ejection fraction in the elderly: pathophysiology, diagnosis and therapeutic approach

Ernesto Ruiz Duque, Alexandros Briasoulis, Paulino A Alvarez

J Geriatr Cardiol. 2019 May; 16(5): 421–428

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558574/

■ Self-management of heart failure in dementia and cognitive impairment: a systematic review

Janaka Lovell, Tony Pham, Samer Q. Noaman et al

BMC Cardiovasc Disord. 2019; 19: 99.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489234/

■ Telemedicina in heart failure – more than nice to have?

G. M. J. Eurlings, J. J. Boyne, R. A. de Boer, H. P. Brunner-La Rocca

Neth Heart J. 2019 Jan; 27(1): 5–15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311157/

■ The impact of cateter ablation for atrial fibrillation in heart failure

Konstantinos Moschonas, Adam Nabeebaccus, Darlington O. Okonko et al

J Arrhythm. 2019 Feb; 35(1): 33–42

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373662/

■ Treating oxidative stress in heart failure: past, presente, and future

A van der Pol, W H van Gilst, A A Voors et al

European Journal of Heart Failure 2019, vol 21 (4): 425-435

https://onlinelibrary.wiley.com/doi/10.1002/ejhf.1320

■ Cardiac contratiligy modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond

C Tschöpe, B Kherad, O Klein et al

European Journal of Heart Failure 2019, vol 21 (1): 14-22

https://onlinelibrary.wiley.com/doi/10.1002/ejhf.1349

■ Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis

M P van den Berg, B A Mulder, S H C Klaassen et al

European Heart Journal 2019, vol 40 (16): 1287-1293

https://academic.oup.com/eurheartj/article/40/16/1287/5310346

■ Heart failure and problems with frailty syndrome: Why it is time to care about frailty syndrome in heart failure

Izabella Uchmanowicz, Agnieszka Młynarska, Magdalena Lisiak et al

Card Fail Rev. 2019 Feb; 5(1): 37–43

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396065/

■ Heart failure and cancer: mechanisms of old and new cardiotoxic drugs in cancer patients

Alessandra Cuomo, Alessio Rodolico, Amalia Galdieri, et al

Card Fail Rev. 2019 May; 5(2): 112–118

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545979/

■ Subclinical left ventricular dysfunction during chemotherapy

Martin Nicol, Mathilde Baudet, Alain Cohen-Solal

Card Fail Rev. 2019 Feb; 5(1): 31–36

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396067/

■ Prognostic value of right ventricular dysfunction or elevated cardiac biomarker in patients with low-risk pulmonary embolism: a systematic review and meta-analysis

S Barco, S H Mahmoudpour, B Planquette et al

European Heart Journal 2019, vol 40 (11): 902-910

https://academic.oup.com/eurheartj/article/40/11/902/5263773

■ Biomarkers of inflammation in left ventricular diastolic dysfunction

Mocan M, Mocan Hognogi LD, Anton FP et al

Dis Markers. 2019 Jun 2;2019:758369

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589287/

■ Natriuretic peptides in chronic heart failure

Hans-Peter Brunner-La Rocca, Sandra Sanders-van Wijk

Card Fail Rev. 2019 Feb; 5(1): 44–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396059/

■ Use of renin-angiotensin-aldosterone system inhibitors in older patients with heart failure and reduced ejection fraction